SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-18-216276
Filing Date
2018-07-12
Accepted
2018-07-11 19:48:04
Documents
3
Group Members
BRIAN M. ISERNSANDRA I. COUFAL, M.D.SIBLING CAPITAL FUND II-A L.P.SIBLING CAPITAL FUND II-B L.P.SIBLING CAPITAL FUND II-C L.P.SIBLING CAPITAL FUND II-D L.P.SIBLING CAPITAL VENTURES II LLCSIBLING CAPITAL VENTURES III LLCSIBLING CAPITAL VENTURES IV LLCSIBLI

Document Format Files

Seq Description Document Type Size
1 SC 13D d379570dsc13d.htm SC 13D 326342
2 EX-99.A d379570dex99a.htm EX-99.A 16031
3 EX-99.B d379570dex99b.htm EX-99.B 31473
  Complete submission text file 0001193125-18-216276.txt   375840
Mailing Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080 415-429-7800
Tricida, Inc. (Subject) CIK: 0001595585 (see all company filings)

IRS No.: 463372526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90549 | Film No.: 18949449
SIC: 2834 Pharmaceutical Preparations

Mailing Address 702 SAN ANTONIO STREET AUSTIN TX 78701
Business Address 702 SAN ANTONIO STREET AUSTIN TX 78701 504-715-8335
Sibling Capital Ventures LLC (Filed by) CIK: 0001744971 (see all company filings)

IRS No.: 463836993 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D